Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. more
Time Frame | SILK | Sector | S&P500 |
---|---|---|---|
1-Week Return | 24.13% | 0.93% | -0.23% |
1-Month Return | 22.66% | 1.85% | 3.09% |
3-Month Return | 45.96% | 1.27% | 4.99% |
6-Month Return | 118.52% | 9.09% | 15.17% |
1-Year Return | -19.07% | 13.44% | 28% |
3-Year Return | -47.62% | 22.7% | 34.03% |
5-Year Return | -42.95% | 71.25% | 101.06% |
10-Year Return | -25.65% | 184.66% | 236.13% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 63.35M | 75.23M | 101.47M | 138.64M | 177.13M | [{"date":"2019-12-31","value":35.77,"profit":true},{"date":"2020-12-31","value":42.47,"profit":true},{"date":"2021-12-31","value":57.29,"profit":true},{"date":"2022-12-31","value":78.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 15.93M | 21.29M | 25.45M | 37.88M | 50.05M | [{"date":"2019-12-31","value":31.82,"profit":true},{"date":"2020-12-31","value":42.54,"profit":true},{"date":"2021-12-31","value":50.84,"profit":true},{"date":"2022-12-31","value":75.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 47.43M | 53.94M | 76.03M | 100.76M | 127.09M | [{"date":"2019-12-31","value":37.32,"profit":true},{"date":"2020-12-31","value":42.44,"profit":true},{"date":"2021-12-31","value":59.82,"profit":true},{"date":"2022-12-31","value":79.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 74.86% | 71.70% | 74.92% | 72.68% | 71.75% | [{"date":"2019-12-31","value":99.92,"profit":true},{"date":"2020-12-31","value":95.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.01,"profit":true},{"date":"2023-12-31","value":95.76,"profit":true}] |
Operating Expenses | 75.49M | 96.80M | 123.50M | 152.77M | 186.36M | [{"date":"2019-12-31","value":40.51,"profit":true},{"date":"2020-12-31","value":51.94,"profit":true},{"date":"2021-12-31","value":66.27,"profit":true},{"date":"2022-12-31","value":81.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (28.07M) | (42.86M) | (47.47M) | (52.00M) | (59.27M) | [{"date":"2019-12-31","value":-2806500000,"profit":false},{"date":"2020-12-31","value":-4285900000,"profit":false},{"date":"2021-12-31","value":-4746800000,"profit":false},{"date":"2022-12-31","value":-5200400000,"profit":false},{"date":"2023-12-31","value":-5927100000,"profit":false}] |
Total Non-Operating Income/Expense | (27.65M) | (7.81M) | (4.66M) | (5.58M) | 6.61M | [{"date":"2019-12-31","value":-417.99,"profit":false},{"date":"2020-12-31","value":-118.13,"profit":false},{"date":"2021-12-31","value":-70.5,"profit":false},{"date":"2022-12-31","value":-84.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (52.41M) | (47.37M) | (49.81M) | (55.01M) | (55.74M) | [{"date":"2019-12-31","value":-5241500000,"profit":false},{"date":"2020-12-31","value":-4736500000,"profit":false},{"date":"2021-12-31","value":-4981100000,"profit":false},{"date":"2022-12-31","value":-5501000000,"profit":false},{"date":"2023-12-31","value":-5574300000,"profit":false}] |
Income Taxes | 3.66M | 3.02M | 576.00K | 3.01M | 43.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":82.56,"profit":true},{"date":"2021-12-31","value":15.75,"profit":true},{"date":"2022-12-31","value":82.18,"profit":true},{"date":"2023-12-31","value":1.18,"profit":true}] |
Income After Taxes | (56.07M) | (50.38M) | (50.39M) | (58.02M) | (55.79M) | [{"date":"2019-12-31","value":-5607300000,"profit":false},{"date":"2020-12-31","value":-5038500000,"profit":false},{"date":"2021-12-31","value":-5038700000,"profit":false},{"date":"2022-12-31","value":-5801600000,"profit":false},{"date":"2023-12-31","value":-5578600000,"profit":false}] |
Income From Continuous Operations | (52.41M) | (47.37M) | (49.81M) | (55.01M) | (55.74M) | [{"date":"2019-12-31","value":-5241500000,"profit":false},{"date":"2020-12-31","value":-4736500000,"profit":false},{"date":"2021-12-31","value":-4981100000,"profit":false},{"date":"2022-12-31","value":-5501000000,"profit":false},{"date":"2023-12-31","value":-5574300000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (56.07M) | (50.38M) | (50.39M) | (58.02M) | (55.74M) | [{"date":"2019-12-31","value":-5607300000,"profit":false},{"date":"2020-12-31","value":-5038500000,"profit":false},{"date":"2021-12-31","value":-5038700000,"profit":false},{"date":"2022-12-31","value":-5801600000,"profit":false},{"date":"2023-12-31","value":-5574300000,"profit":false}] |
EPS (Diluted) | (21.07) | (1.44) | (1.44) | (1.54) | (1.44) | [{"date":"2019-12-31","value":-2107,"profit":false},{"date":"2020-12-31","value":-144,"profit":false},{"date":"2021-12-31","value":-144,"profit":false},{"date":"2022-12-31","value":-154,"profit":false},{"date":"2023-12-31","value":-144,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SILK | |
---|---|
Cash Ratio | 8.18 |
Current Ratio | 11.05 |
Quick Ratio | 9.62 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SILK | |
---|---|
ROA (LTM) | -13.99% |
ROE (LTM) | -35.04% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SILK | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.42 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.58 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 1.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SILK | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 4.03 |
P/B | 4.71 |
Price/FCF | NM |
EV/R | 3.43 |
EV/Ebitda | NM |
PEG | NM |
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Medical, Inc. (NasdaqGS: SILK) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Silk Road will receive $27.50 in cash for each share of Silk Road that they own. KSF is seeking Jetzt den vollständigen Artikel lesen
Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for $27.50 per share, reflecting an enterprise value of approximately $1.16 billion. This transaction, which is a 38% premium over the volume-weighted average share price of Silk Road Medical’s stock over the past 60 days, is expected […]
NEW YORK, June 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Silk Road Medical, Inc. (NASDAQ: SILK)''s…
Silk Road is headquartered in California but in recent years has expanded to the Twin Cities.
Boston Scientific Acquires Silk Road Medical to Strengthen Vascular Portfolio
Boston Scientific has purchased Silk Road Medical, which makes products to help prevent strokes in patients with carotid artery disease.
Silk Road Medical Inc (SILK) share price today is $26.9
Yes, Indians can buy shares of Silk Road Medical Inc (SILK) on Vested. To buy Silk Road Medical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SILK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Silk Road Medical Inc (SILK) via the Vested app. You can start investing in Silk Road Medical Inc (SILK) with a minimum investment of $1.
You can invest in shares of Silk Road Medical Inc (SILK) via Vested in three simple steps:
The 52-week high price of Silk Road Medical Inc (SILK) is $33.13. The 52-week low price of Silk Road Medical Inc (SILK) is $6.08.
The price-to-earnings (P/E) ratio of Silk Road Medical Inc (SILK) is NM
The price-to-book (P/B) ratio of Silk Road Medical Inc (SILK) is 4.71
The dividend yield of Silk Road Medical Inc (SILK) is 0.00%
The market capitalization of Silk Road Medical Inc (SILK) is $1.06B
The stock symbol (or ticker) of Silk Road Medical Inc is SILK